92 related articles for article (PubMed ID: 16151774)
1. Problems in the investigation of urine from patients suffering from primary hyperoxaluria type 1.
Laube N; Hoppe B; Hesse A
Urol Res; 2005 Nov; 33(5):394-7. PubMed ID: 16151774
[TBL] [Abstract][Full Text] [Related]
2. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
[TBL] [Abstract][Full Text] [Related]
3. The alteration of urine composition due to stone material present in the urinary tract.
Laube N; Pullmann M; Hergarten S; Schmidt M; Hesse A
Eur Urol; 2003 Nov; 44(5):595-9. PubMed ID: 14572760
[TBL] [Abstract][Full Text] [Related]
4. Calcium oxalate stone formation risk - a case of disturbed relative concentrations of urinary components.
Laube N; Rodgers A; Allie-Hamdulay S; Straub M
Clin Chem Lab Med; 2008; 46(8):1134-9. PubMed ID: 18578688
[TBL] [Abstract][Full Text] [Related]
5. A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.
Porowski T; Zoch-Zwierz W; Konstantynowicz J; Taranta-Janusz K
Pediatr Nephrol; 2008 Jul; 23(7):1123-8. PubMed ID: 18335253
[TBL] [Abstract][Full Text] [Related]
6. Analytical precision of the Urolizer for the determination of the BONN-Risk-Index (BRI) for calcium oxalate urolithiasis and evaluation of the influence of 24-h urine storage at moderate temperatures on BRI.
Berg W; Bechler R; Laube N
Clin Chem Lab Med; 2009; 47(4):478-82. PubMed ID: 19222375
[TBL] [Abstract][Full Text] [Related]
7. Clinical validation of urinary indole-reacted calcium oxalate crystallization index (iCOCI) test for diagnosing calcium oxalate urolithiasis.
More-Krong P; Tubsaeng P; Madared N; Srisa-Art M; Insin N; Leeladee P; Boonla C
Sci Rep; 2020 May; 10(1):8334. PubMed ID: 32433482
[TBL] [Abstract][Full Text] [Related]
8. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous urinary calcium oxalate crystallization in hypercalciuric children.
Porowski T; Konstantynowicz J; Zoch-Zwierz W; Kirejczyk JK; Taranta-Janusz K; Korzeniecka-Kozerska A
Pediatr Nephrol; 2009 Sep; 24(9):1705-10. PubMed ID: 19350280
[TBL] [Abstract][Full Text] [Related]
10. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.
Worcester EM; Evan AP; Coe FL; Lingeman JE; Krambeck A; Sommers A; Phillips CL; Milliner D
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1574-84. PubMed ID: 24089413
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of crystalluria study].
Daudon M; Jungers P; Lacour B
Ann Biol Clin (Paris); 2004; 62(4):379-93. PubMed ID: 15297232
[TBL] [Abstract][Full Text] [Related]
12. [Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
Laube N; Schmidt M; Hesse A
Urologe A; 2003 Feb; 42(2):243-9. PubMed ID: 12607094
[TBL] [Abstract][Full Text] [Related]
13. Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?
Laube N; Hergarten S
J Urol; 2005 Jun; 173(6):2175-7. PubMed ID: 15879882
[TBL] [Abstract][Full Text] [Related]
14. Relevance of the BONN Risk Index for metabolic monitoring of patients with calcium oxalate urolithiasis: a clinical application study of the Urolizer.
Berg W; Bechler R; Haas C; Laube N
Urol Res; 2009 Apr; 37(2):55-62. PubMed ID: 19205684
[TBL] [Abstract][Full Text] [Related]
15. The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization.
Laube N; Zimmermann DJ
Clin Chem Lab Med; 2004; 42(6):665-9. PubMed ID: 15259384
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria.
Brooks ER; Hoppe B; Milliner DS; Salido E; Rim J; Krevitt LM; Olson JB; Price HE; Vural G; Langman CB
Am J Nephrol; 2016; 43(4):293-303. PubMed ID: 27161247
[TBL] [Abstract][Full Text] [Related]
17. Testing the predictability of the relative urinary supersaturation from the Bonn-Risk-Index for calcium oxalate stone formation.
Laube N; Hergarten S; Hesse A
Clin Chem Lab Med; 2001 Oct; 39(10):966-9. PubMed ID: 11758612
[TBL] [Abstract][Full Text] [Related]
18. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation.
Porowski T; Mrozek P; Sidun J; Zoch-Zwierz W; Konstantynowicz J; Kirejczyk JK; Motkowski R; Laube N
J Urol; 2010 Mar; 183(3):1157-62. PubMed ID: 20096860
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of calcium oxalate crystal formation in urine.
Laube N; Klein F; Bernsmann F
Urolithiasis; 2017 Apr; 45(2):151-157. PubMed ID: 27328814
[TBL] [Abstract][Full Text] [Related]
20. Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?
Rodgers AL; Webber D; Hibberd B
Urolithiasis; 2015 Nov; 43(6):479-87. PubMed ID: 26198547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
